此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effects of a Self-Regulation Based E-MOTE Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients

2026年7月30日 更新者:National Taiwan University Hospital

Effects of a Self-Regulation-Based E-MOTE Emotional Care Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients From Surgery to 6-Month Post-Discharge

To evaluate the effectiveness of the E-MOTE Emotional Care Program, delivered through the Kebbi robot and the LINE Official Account, for patients newly diagnosed with gynecologic cancer undergoing surgery. The primary outcomes are psychological distress , and the secondary outcomes are physical symptoms, stress index, and quality of life.

研究概览

地位

尚未招聘

研究类型

介入性

注册 (估计的)

120

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Yun-Hsiang Lee Associate Professor, PhD
  • 电话号码:+886 978082338
  • 邮箱:yhlee338@ntu.edu.tw

学习地点

      • Taipei、台湾
        • National Taiwan University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

描述

***Patients***

Inclusion Criteria:

  • Aged 18 years or older.
  • Diagnosed with gynecologic cancer and undergoing surgery.
  • Willing to receive E-MOTE robot and wear a smart wearable device.
  • Willing to complete pre-test and post-test questionnaires.

Exclusion Criteria:

  • Unable to communicate clearly.
  • Unwilling or unable to participate in the study in its entirety.

***Nurse***

Inclusion Criteria:

  • Aged 18 years or older.
  • As a clinical nurse and has cared for patients who received the E-MOTE robot

Exclusion Criteria:

- Unwilling to participate in the qualitative interview.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
无干预:对照组
日常护理
实验性的:Intervention Group
The intervention group will receive the E-MOTE program, which includes emotional assessments, a self-relaxation training session, and a Q&A session delivered via the Kebbi AI robot during hospitalization. After discharge, participants will continue to receive the program through the LINE Official Account.
Participants in the experimental group will receive the E-MOTE program during hospitalization on the day before surgery, postoperative day 1, and postoperative day 2 via the AI robot. The intervention includes an emotional assessment, followed by dialogue modules tailored to the participant's level of emotional distress, emotion-generated empathetic conversations, a self-affirmation relaxation training session, and a Q&A session. After discharge, participants will continue to receive the E-MOTE program through the LINE Official Account.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
痛苦
大体时间:测量将在干预前、手术后三天以及出院后一周进行。
研究人员采用痛苦温度计(DT)作为主要结局指标。 该量表采用11级李克特量表,其中0表示完全没有痛苦,10表示最严重的痛苦。分数越高表明痛苦越严重。 当分数达到4分或更高时,会使用问题清单(PL)进一步识别导致情绪痛苦的因素。
测量将在干预前、手术后三天以及出院后一周进行。
Depression
大体时间:Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Investigators utilized the Patient Health Questionnaire (PHQ-9) as the primary outcome measure to assess depression. The scale consists of 9 items, each rated on a 4-point Likert scale (0 = not at all, 3 = nearly every day). The total score ranges from 0 to 27, and depression severity can be categorized as mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20 or above).Higher score indicates a more severe depression.
Measurements will be taken before the intervention, three days after surgery, and one week after discharge

次要结果测量

结果测量
措施说明
大体时间
Quality of Life Measurement
大体时间:Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Investigator use the partial itmes of European Organisation for Research and Treatment of Cancer (EORTC QLQ-C30) to measure quality of life. These two item is scored on a scale from 1 to 7, with higher scores indicating better quality of life.
Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Symptom Severity
大体时间:Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Investigators utilized the Numerical Rating Scale to assess participants' subjective experiences by measuring the severity of various symptoms over the past week. Each symptom was rated on a scale from 0 to 10 (0 = no symptoms at all, 10 = the worst severity the participant can imagine). Higher score indicate more severity. This items included difficulty urinating, lower limb lymphedema, hot flashes caused by premature menopause, and perineal dryness.
Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Stress Index
大体时间:Measurements will be taken before the intervention, three days after surgery, and one week after discharge
Objective physiological indicators were measured using wearable smart wristbands, and heart rate variability (HRV) was converted into a stress index using a predefined formula.
Measurements will be taken before the intervention, three days after surgery, and one week after discharge

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年9月1日

初级完成 (估计的)

2028年7月31日

研究完成 (估计的)

2028年7月31日

研究注册日期

首次提交

2026年7月30日

首先提交符合 QC 标准的

2026年7月30日

首次发布 (实际的)

2026年8月4日

研究记录更新

最后更新发布 (实际的)

2026年8月4日

上次提交的符合 QC 标准的更新

2026年7月30日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • 202602068RINC

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅